SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer

 SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer

SDSC and Moores Cancer Center Collaboratively Work with CureMatch to Develop Machine Learning Model for the Diagnosis of Bladder Cancer

Shots:

  • The machine learning model utilizes MLP (multi-layer perceptron) software, providing a non-invasive diagnostic option, analyzes a patient’s metabolites and their chemical descriptors, generating AI models to detect and identify the stage of cancer
  • The focus of the research is to minimize the number of cancer cases & to create an ease for patients to know about the life-threatening bladder cancer by examining their urine and further the ML system produces a red flag analysis on detection of cancer
  • The model uses multiple computational tools to examine the pathways associated with different bladder cancer stages, useful in diagnostics and the monitoring of disease progression

Click here to read full press release/ article | Ref: SDSC | Image: Verdict Medical Devices

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post